Steroid withdrawal in kidney allograft recipients

References

• Murray JE, Tilney NL, Wilson RE. Renal transplantation: a twenty-five year experience. Ann Surg 1976;184(5):565-73
   Web of Science ®Google Scholar
• Berlanda M, Di Cocco P, Mazzotta C, et al. Clinical operational tolerance after kidney transplantation: a short literature review. Transplant Proc 2008;40(6):1847-51
   Google Scholar
• Markic D, Valencic M, Maricic A, et al. Kidney transplantation – a successful story started 110 years ago. Acta Med Croatica 2012;66(2):59-63
   Google Scholar
• Baker R, Gordon R. Effect of total body irradiation on experimental renal transplantation. Surgery 1955;37(5):820-2
   Google Scholar
• Mitchell RM, Budtz-Olsen OE, Stevens BG, Devereux GA. Sublethal total body irradiation and renal transplantation. Transplantation 1963;1:388-90
   Google Scholar
• Perez R, Gluckmann A. [Total irradiation of the body in man in relation to tissue grafts or organ transplantation]. Fr Med 1963;26:355-62
   Google Scholar
• Keitel E, dos Santos AF, Bittar AE, et al. Twenty-five year experience with renal transplantation at Santa Casa Hospital, Porto Alegre. Clin Transpl 2002;163-70
   Google Scholar
• Starzl TE, Marchioro TL, Talmage DW, Waddell WR. Splenectomy and thymectomy in human renal homotransplantation. Proc Soc Exp Biol Med 1963;113:929-32
   PubMedGoogle Scholar
• Veith FJ, Luck RJ, Murray JE. The effects of splenectomy on immunosuppressive regimens in dog and man. Surg Gynecol Obstet 1965;121:299-308
   PubMedGoogle Scholar
• Caline RY. Thymectomy in dogs with renal homografts treated with drugs. Nature 1963;199:388-9
   Google Scholar
• Shikata T. Selective irradiation of lymph nodes with transitory ligation of the thoracic duct as an immunosuppressive measure in renal transplantation. Tohoku J Exp Med 1968;94(1):55-61
   Google Scholar
• Block M. Effect of immunosuppressive therapy for renal transplantation in man on marrow and blood. Bibl Haematol 1968;29:1195
   Google Scholar
• Abbott WM, Otherson HB, Monaco AP, et al. Prolonged survival of renal allografts in dogs treated with anti-lymphocyte serum. Surg Forum 1966;17:228-30
   Google Scholar
• Huntley RT, Taylor PD, Iwasaki Y, et al. Use of anti-lymphocyte serum to prolong dog homograft survival. Surg Forum 1966;17:230-3
   Google Scholar
• Curtis J. Corticosteroids and kidney transplantation. Clin J Am Soc Nephrol 2006;1(5):907-8
   Google Scholar
• Prasad GV, Nash MM, McFarlane PA, Zaltzman JS. Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 2003;17(2):135-9
   Google Scholar
• Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006;6(5 Pt 2):1111-31
   PubMed Web of Science ®Google Scholar
• Shapiro R, Young JB, Milford EL, et al. Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant 2005;5(4 Pt 2):874-86
   Google Scholar
• Vincenti F. A decade of progress in kidney transplantation. Transplantation 2004;77(Suppl 9):S52-61
   Google Scholar
• Zhang R, Kumar P, Ramcharan T, Reisin E. Kidney transplantation: the evolving challenges. Am J Med Sci 2004;328(3):156-61
   Google Scholar
• El-Charabaty E, Geara AS, Ting C, et al. Belatacept: a new era of immunosuppression? Expert Rev Clin Immunol 2012;8(6):527-36
   PubMed Web of Science ®Google Scholar
• Veenstra DL, Best JH, Hornberger J, et al. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999;33(5):829-39
   PubMedGoogle Scholar
• Gheith OA, Nematalla AH, Bakr MA, et al. Cost–benefit of steroid avoidance in renal transplant patients: a prospective randomized study. Scand J Urol Nephrol 2010;44(3):175-82
   PubMed Web of Science ®Google Scholar
• Chang SH, Russ GR, Chadban SJ, et al. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005. Nephrology (Carlton) 2008;13(2):171-6
   Google Scholar
• Matas AJ, Ramcharan T, Paraskevas S. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 2001;1:278-83
   Google Scholar
• Gonzalez-Molina M, Gentil MA, Burgos D, et al. Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study. NDT Plus 2010;3(Suppl 2):ii32-6
   PubMedGoogle Scholar
• Hricik DE, O’Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993;4(6):1300-5
   PubMedGoogle Scholar
• Hricik DE, Knauss TC, Bodziak KA, et al. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2003;76(6):938-42
   Google Scholar
• Hricik DE, Augustine JJ, Knauss TC, et al. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2007;83(3):277-81
   Google Scholar
• Vanrenterghem Y, van Hooff JP, Squifflet JP, et al. Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am J Transplant 2005;5(1):87-95
   PubMed Web of Science ®Google Scholar
• Sinclair NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. CMAJ 1992;147(5):645-57
   PubMed Web of Science ®Google Scholar
• Arnol M, de Mattos AM, Chung JS. Late steroid withdrawal and cardiovascular events in kidney transplant recipients. Transplantation 2008;86:1844-8
   Google Scholar
• Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000;11(10):1910-17
   PubMedGoogle Scholar
• Opelz G, Dohler B, Laux G; Collaborative Transplant Study. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005;5(4 Pt 1):720-8
   Google Scholar
• Rama I, Cruzado JM, Gil-Vernet S, et al. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results. Transplantation 2005;80(2):164-8
   Google Scholar
• Smak Gregoor PJ, de Sevaux RG, Ligtenberg G, et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J Am Soc Nephrol 2002;13(5):1365-73
   Google Scholar
• Birkeland SA. Steroid free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Clin Transplant 1998;66(9):1207-10
   Google Scholar
• Cole E, Landsberg D, Russell D, et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Clin Transplant 2001;72(5):845-50
   Google Scholar
• Vincenti F, Schena FP, Paraskevas S. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008;8:307-16
   PubMed Web of Science ®Google Scholar
• Woodle ES, First MR, Pirsch J, et al. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008;248:564-77
   PubMed Web of Science ®Google Scholar
• Filipe R, Mota A, Alves R, et al. Kidney transplantation with corticosteroid-free maintenance immunosuppression: a single center analysis of graft and patient survivals. Transplant Proc 2009;41(3):843-5
   Google Scholar
• Pascual J, Zamora J, Galeano C, et al. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009(1):CD005632
   Google Scholar
• Rajab A, Pelletier RP, Henry ML. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin. Transplant 2006;20:537-46
   PubMed Web of Science ®Google Scholar
• Solez K, Colvin RB, Racusen LC, et al. Banff ‘05 Meeting Report: differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’). Am. J. Transplant 2007;7(3):518-26
   PubMed Web of Science ®Google Scholar
• Haynes R, Baigent C, Harden P, et al. Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol. Transplant Res 2013;2(1):7
   Google Scholar
• Nankivell B, Borrows R, Fung C, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003;349(24):2326-33
   PubMedGoogle Scholar
• Roodnat J, Hilbrands LB, Hene RJ, et al. 15 year follow up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation 2014;98(1):47-53
   PubMed Web of Science ®Google Scholar
• Lemieux I, Houde I, Pascot A, et al. Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney Int 2002;62(5):1839-47
   Google Scholar
• Rogers CC, Alloway RR, Hanaway M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplant Proc 2005;37(2):800-1
   Google Scholar
• Ingulli E, Tejani A, Markell M. The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era. Transplantation 1993;55(5):1029-33
   Google Scholar
• Sprangers B, Kuypers D. Recurrence of glomerulonephritis after renal transplantation. Transplant Rev 2013;27(4):126-34
   Web of Science ®Google Scholar
• Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006;6(11):2535-42
   Google Scholar
• Von Visger J, Gunay Y, Andreoni K, et al. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression. Clin Transplant 2014. [Epub ahead of print]
   Google Scholar
• Pascual J, Royuela A, Galeano C, et al. Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review. Nephrol. Dial. Transplant 2012;27(2):825-32
   PubMed Web of Science ®Google Scholar
• Nghiem DD, Carpenter BJ, Schlosser JD, et al. The cost of steroid-free protocols in primary cadaver kidney transplantation. Transplant Proc 2005;37(4):1797-9
   Google Scholar
• Gheith OA, Nematalla AH, Bakr MA, et al. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study. Exp Clin Transplant 2011;9(2):121-7
   Web of Science ®Google Scholar
• Woodle ES, Peddi VR, Tomlanovich S, et al.C. TRIMS Study Investigators. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin® in living-donor kidney transplantation. Clin Transplant 2010;24(1):73-83
   PubMedGoogle Scholar
• Matas AJ, Kandaswamy R, Gillingham KJ. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005;5:2473-8
   Google Scholar
• Chhabra D, Skaro AI, Leventhal JR, et al. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Clin J Am Soc Nephrol 2012;7(3):504-12
   Google Scholar
• Meier-Kriesche H-U, Schold JD, Srinivas TR, et al. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005;5(9):2273-80
   Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009;9(Suppl 3):S1-155
   PubMedGoogle Scholar
• Zeng X, El-Amm JM, Doshi MD, et al. Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy. Surgery 2007;142(4):538-45
   Google Scholar
• Henderson LK, Nankivell BJ, Chapman JR. Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice. Am J Transplant 2011;11:1570-5
   Web of Science ®Google Scholar
• Lipman ML, Lavery P, Shi Y, et al. Incidence of subclinical rejection in protocol biopsies procured from renal transplant recipients on tacrolimus-based immunosuppressive regimen. Am J Transplant 2004;4(Suppl 8):551
   Google Scholar
• Shimizu T, Tanabe K, Ishida H, et al. Detection of subclinical humoral and/or vascular rejection by protocol biopsies in highly sensitized renal transplant recipients. Am J Transplant 2004;4(8):206
   Google Scholar
• Laftavi MR, Stephan RN, Stephanik BK, et al. The significance of protocol biopsies in the modern immunosuppressive era; what for? Am J Transplant2004;4(8):352
   Google Scholar
• Schold JD, Santos A, Rehman S, et al. The success of continued steroid avoidance after kidney transplantation in the US. Am J Transplant 2009;9(12):2768-76
   Google Scholar
• Ponticelli C. Present and future of immunosuppressive therapy in kidney transplantation. Transplant Proc 2011;43(6):2439-40
   PubMed Web of Science ®Google Scholar
• Ishida Y, Heersche JN. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 1998;13(12):1822-6
   PubMed Web of Science ®Google Scholar
• Da Silva JA, Jacobs JW, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006;65(3):285-93
   PubMed Web of Science ®Google Scholar
• Kishikawa H, Nishimura K, Soda T, et al. Low-dose steroid maintenance for renal transplant recipients. Transplant Proc 2010;42(10):4030-2
   Google Scholar
• Steiner R, Awdishu L. Steroids in kidney transplant patients. Semin Immunopathol 2011;33(2):157-67
   Google Scholar